Recombinant Human C5orf39 293 Cell Lysate

• Cat.No.: ANXA2R-8010HCL

Specification

• Description: Antigen standard for chromosome 5 open reading frame 39 (C5orf39) is a lysate prepared from HEK293T cells transiently transfected with a TrueORF gene-carrying pCMV plasmid and then lysed in RIPA Buffer. Protein concentration was determined using a colorimetric assay. The antigen control carries a C-terminal Myc/DDK tag for detection.
• Source: HEK 293 cells
• Species: Human
• Components: This product includes 3 vials: 1 vial of gene-specific cell lysate, 1 vial of control vector cell lysate, and 1 vial of loading buffer. Each lysate vial contains 0.1 mg lysate in 0.1 ml (1 mg/ml) of RIPA Buffer (50 mM Tris-HCl pH7.5, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% NP40). The loading buffer vial contains 0.5 ml 2X SDS Loading Buffer (125 mM Tris-Cl, pH6.8, 10% glycerol, 4% SDS, 0.002% Bromophenol blue, 5% beta-mercaptoethanol).
• Size: 0.1 mg
• Storage Instruction: Store at -80°C. Minimize freeze-thaw cycles. After addition of 2X SDS Loading Buffer, the lysates can be stored at -20°C. Product is guaranteed 6 months from the date of shipment.
• Applications: ELISA, WB, IP. WB: Mix equal volume of lysates with 2X SDS Loading Buffer. Boil the mixture for 10 min before loading (for membrane protein lysates, incubate the mixture at room temperature for 30 min). Load 5 ug lysate per lane.
• Tag: Non

Gene Information

• Gene Name: ANXA2R annexin A2 receptor [ Homo sapiens ]
• Official Symbol: ANXA2R
• Synonyms: AX2R; AXIIR; C5orf39; annexin-2 receptor; annexin II receptor
• Gene ID: 389289
• mRNA Refseq: NM_001014279
• Protein Refseq: NP_001014301
• MIM: 611296
• UniProt ID: Q3ZCQ2
• Chromosome Location: 5p12

Reviews

05/30/2021

Highly recommended and known for its outstanding performance in ELISA, the ANXA2R protein is a top choice for researchers in protein electron microscopy structure analysis.

02/09/2021

Its versatility and reliability make it a great asset in the pursuit of scientific discoveries.

05/22/2018

Its exceptional properties and reliable results make it a valuable tool in various experimental applications.

07/12/2017

With the ANXA2R protein, researchers can confidently delve into the complexity of protein structures and gain deeper insights into their functions.

Q&As

Are there any diseases associated with ANXA2R?

ANXA2R has been implicated in cancer progression and metastasis. It is highly expressed in several cancer types, and its overexpression has been associated with poor prognosis. ANXA2R has also been suggested to play a role in autoimmune diseases and pathogen infection, although more research is needed to establish these associations.

Are there any therapeutic implications for targeting ANXA2R?

Targeting ANXA2R has shown potential for therapeutic purposes. In cancer, blocking ANXA2R or its interaction with Annexin A2 may inhibit tumor invasion and metastasis. This could be achieved through the development of small molecule inhibitors, antibodies, or peptides that disrupt ANXA2R function. Additionally, modulating ANXA2R activity might be useful in cardiovascular diseases and autoimmune disorders, although more research is needed to identify specific therapeutic strategies.

Can ANXA2R interact with other proteins?

Yes, ANXA2R can interact with a variety of proteins. One of its well-known interactions is with Annexin A2, forming a receptor-ligand complex. It can also interact with other cell adhesion molecules, signaling proteins, and cytoskeletal proteins, contributing to its diverse functions.

Can ANXA2R be used as a diagnostic or prognostic marker?

ANXA2R has shown promise as a diagnostic and prognostic marker in certain cancers. Its overexpression has been associated with poor prognosis in breast cancer, colorectal cancer, and ovarian cancer. However, further studies are needed to validate its utility as a clinical marker in different diseases.

How is ANXA2R expressed in different tissues?

ANXA2R is expressed in various tissues and cell types. It has been detected in the endothelium, epithelium, smooth muscle cells, and neurons. Its expression levels can vary depending on the tissue type and physiological context.

How is ANXA2R implicated in cancer?

ANXA2R has been implicated in cancer through its involvement in processes such as cell migration, invasion, and metastasis. Its overexpression has been observed in various types of cancer and is often associated with poor prognosis. ANXA2R can promote tumor cell invasion by interacting with Annexin A2 and other proteins involved in cell adhesion and cytoskeletal rearrangement. Furthermore, ANXA2R can modulate signaling pathways that contribute to tumor growth and survival.

Are there any ongoing research studies related to ANXA2R?

Yes, there are ongoing research studies investigating various aspects of ANXA2R. Some studies aim to elucidate the precise role of ANXA2R in cancer progression, as well as its potential as a therapeutic target. Other studies focus on understanding ANXA2R's involvement in cardiovascular diseases, autoimmune disorders, and other pathological conditions. Additionally, continuing research aims to identify novel molecular mechanisms and signaling pathways associated with ANXA2R.

How is ANXA2R related to Annexin A2?

ANXA2R is the receptor for Annexin A2. Annexin A2 is a calcium-dependent phospholipid-binding protein that interacts with ANXA2R to form a receptor-ligand complex. This complex is involved in various cellular functions, including the regulation of cell adhesion and membrane trafficking.

How is ANXA2R regulated?

ANXA2R expression and activity can be regulated at multiple levels. Transcriptional regulation by various transcription factors can influence ANXA2R expression. Post-translational modifications, such as phosphorylation and glycosylation, can modulate its function and localization. Furthermore, signaling pathways, growth factors, and cytokines can regulate ANXA2R activity, affecting its interactions with other proteins and downstream signaling events.

Is ANXA2R involved in any other diseases or conditions?

Apart from cancer, ANXA2R has been implicated in several other diseases and conditions. It has been associated with cardiovascular diseases, such as atherosclerosis and cardiac fibrosis, playing a role in vascular remodeling, endothelial dysfunction, and inflammation. ANXA2R has also been linked to autoimmune disorders like rheumatoid arthritis and systemic lupus erythematosus, potentially contributing to immune dysregulation and tissue damage.